In breast cancer, CREBBP acetylates RB1CC1 at K276, preventing its ubiquitination and degradation, thereby stabilizing RB1CC1, enhancing autophagy, and promoting resistance under stress conditions [75]. Here, RB1CC1 is linked to breast carcinoma.